RecruitingChronic Hand EczemaAtopic Dermatitis
Characterization of Chronic Hand Eczema
Eligible age
18–65 yrs
Accepts
All genders
Locations
0 states
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Prospective longitudinal study to characterize Choronic Hand Eczema (CHE) subtypes and Atopic Dermatitis (AD) with noninvasive molecular and imaging techniques, and assess changes through time and its association with quality of life.
Sponsor: Dr. Robert Bissonnette
You may qualify if…
- ✓ All subjects:
- ✓ 1. Male or female subjects aged 18 to 65 years, inclusive, at the time of consent.
- ✓ 2. Subject is willing to participate and is capable of giving informed consent. Note: Consent must be obtained prior to any study-related procedures.
- ✓ 3. Subject must be willing to comply with all study procedures and must be available for the duration of the study.
- ✓ CHE subjects only:
- ✓ 4. Subject has at least a 6-month history of CHE before Screening (information obtained from medical chart or subject's physician, or directly from the subject).
- ✓ 5. Subject has moderate to severe CHE as defined by an IGA score of ≥3 at Screening and Day 1.
- ✓ 6. Subject has CHE covering ≥0.25% of BSA on palmar surface of hands at Screening and Day 1.
You may not qualify if…
- ✕ All subjects:
- ✕ 1. Subject has a history of skin disease or presence of skin condition that, in the opinion of the investigator, would interfere with the study assessments.
- ✕ 2. Subject has used systemic antibiotics within 2 weeks prior to Day 1.
- ✕ 3. Subject has used topical antibiotics within 1 week prior to Day 1.
- ✕ 4. Subject has used topical products containing urea or salicylic acid within 1 week prior to Day 1.
- ✕ 5. Subject has received any marketed or investigational biological agent within 12 weeks or 5 half-lives (whichever is longer) prior to Day 1.
- ✕ 6. Subject is currently receiving a nonbiological investigational product or device or has received one within 4 weeks prior to Day 1.
- ✕ 7. Subject has had excessive sun exposure, is planning a trip to a sunny climate, or has used tanning booths within 4 weeks prior to Day 1. Use of sunscreen products are recommended when exposure cannot be avoided.
Source: ClinicalTrials.gov · NCT05026554 · last updated 2026-04-09